Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02636322 |
|---|---|
| Brief Title: | Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib |
| First Submitted : | December 17, 2015 |
| First Submitted that Met QC Criteria : | December 18, 2015 |
| First Posted : | December 21, 2015 (Estimate) |
| Results First Submitted : | September 28, 2023 |
| Results First Submitted that Met QC Criteria : | February 13, 2024 |
| Results First Posted : | March 13, 2024 |
| Last Update Submitted that Met QC Criteria : | February 13, 2024 |
| Last Update Posted : | March 13, 2024 |